• Mashup Score: 1

    September 20, 2022 —  An analysis from the Society of Thoracic Surgeons/American College of Cardiology(STS/ACC) TVT Registry found that most patients with severe mitral regurgitation (MR) and cardiogenic shock (CS) who underwent mitral transcatheter edge-to-edge repair (TEER) in the United States achieved successful MR reduction, and that successful repair was associated with lower mortality and…

    Tweet Tweets with this article
    • @DAICeditor @crfheart An analysis from #STS/#ACC #TVT Registry found most patients with severe mitral regurgitation and #cardiogenicshock who underwent #mitral #transcatheter edge-to-edge repair (#TEER) in the US achieved successful MR reduction: https://t.co/tr97hlVFJc #TCT2022

  • Mashup Score: 3

    A decade ago, when transcatheter aortic valve replacement (TAVR) was first cleared by the U.S. Food and Drug Administration (FDA), many expected TAVR would only be used in a small portion of patients, and surgeons had concerns about losing business. A decade on, the unexpected happened, and it turns out with TAVR, everyone is a winner, including the patient, interventional cardiologist, hospitals…

    Tweet Tweets with this article
    • Cardiac surgeons gaining procedural volume despite TAVR making up 84% of cases #cardiotwitter #structuralheart #TAVR #TAVI #SAVR #TVT #TVT2022 #TVT22 #TCT22 #TCT2022 https://t.co/JxUfNG827y

  • Mashup Score: 0

    Maini was a pioneer in the heart team approach with the development of transcatheter aortic valve replacement (TAVR) a decade ago. This model included the interventional cardiologist, cardiac surgeon, interventional sonographer, cardiac imager or radiologist, nursing, patient navigator and other support staff so everyone is on the same page and has a say in selecting patients for transcatheter…

    Tweet Tweets with this article
    • VIDEO: How to build a collaborative heart team in structural heart #Structuralheart #Cardiotwitter #TVT #Cathlab #TAVR #TMVR #cardiology https://t.co/q4AZb1HSS6

  • Mashup Score: 7

    Michael Mack, MD, chairman of the cardiovascular service line, Baylor, Scott, White Health, cardiac surgeon, and a key pioneer in transcatheter aortic valve replacements (TAVR), explains the history of TAVR and where things are headed during the 2022 Transcatheter Valve Therapeutics (TVT) structural heart summit. TAVR in 2022 makes up about 84% of the aortic valve replacement procedure volume,…

    Tweet Tweets with this article
    • VIDEO: The state of TAVR in 2022 #cardiotwitter #cardiology #TAVR #TVT @bswhealth https://t.co/RbhBoHQl1I

  • Mashup Score: 2

    She discusses the two FDA cleared LAA occlusion (LAAO) devices, the Boston Scientific Watchman FLX and the Abbott Amulet, and new devices in development or already in trials. These include the CLAAS Conformal, Laminar, LAmbre and devices that may combine ablation with LAAO.  Nair also discusses use of CT imaging to help size and preplan the LAA closure procedures and how transesophageal echo…

    Tweet Tweets with this article
    • VIDEO: Advances in left atrial appendage occlusion technology #cardiotwitter #EPeeps #LAA #LAAO #TVT #TVT2022 #structuralheart https://t.co/mCfrZ1MaSq

  • Mashup Score: 0

    He explained the key elements required include:    1. Champion interventional cardiologists and cardiac surgeons who can work together as a team and share decision making for what is best for the patient.    2. Interventional imagers who can work as a key part of the team for pre-procedural evaluations and guide imaging during procedures. This is usually a dedicated interventional…

    Tweet Tweets with this article
    • VIDEO: How to build a structural heart program #TVT #TVT22 #TVT2022 #cardiotwitter #structuralheart #TAVR #TMVR @NorthwesternMed https://t.co/NFvmThsrD2

  • Mashup Score: 6
    TCT 2021 - 3 year(s) ago

    Educational Grant SupportTCT is sponsored by the Cardiovascular Research Foundation (CRF) and partially funded through educational grants from commercial supporters.This program is made possible in part by the educational grant support of our industry colleagues who, like CRF, are dedicated to educating medical professionals and the public to enhance patient outcomes. CRF gratefully acknowledges…

    Tweet Tweets with this article
    • Curious about #TVT studies, plaque modification, #endovascular interventions, or #antiplatelet drug studies? Don't miss today's poster sessions at #TCT2021. https://t.co/RLWjT6RHxB @JoaoLCavalcante @brijmaini @NWeissmanMD @jgschwartzmd @IssamDMoussa1 @DrBillGray @SandeepNathanMD https://t.co/QsL5GXjF4U